Is Vertex Pharmaceuticals Stock a Buy Now?
Vertex Pharmaceuticals (NASDAQ: VRTX) is a growing business that generates billions in annual profit and has some incredible opportunities ahead. It's easy to see why investors are bullish on the stock and why it's continuing to do well this year, up 24%.
At 27 times earnings, however, it's not a terribly cheap stock to own. And at that valuation, you should be expecting some considerable growth from the business. According to at least one popular TV personality, there is plenty of that out there.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
466,00 €
-0,42 %
Vertex Pharmaceuticals Inc. ist ein klarer Community-Favorit mit mehr Buy- als Sell-Einschätzungen.
Trotz eines Kursziels von 450 €, das unter 466.0 € liegt, ergibt sich für Vertex Pharmaceuticals Inc. ein negatives Potenzial von -3.43%.
